The Evidence Based Rheumatology Podcast podcast

E115: Benralizumab for EGPA - the MANDARA Study

0:00
9:52
Rewind 15 seconds
Fast Forward 15 seconds

Quick rundown of an important rheumatology RCT this week, discussing the IL-5 inhibitor benralizumab for the treatment of relapsing/refractory EGPA. 

 

MANDARA Study: https://www.nejm.org/doi/full/10.1056/NEJMoa2311155

More episodes from "The Evidence Based Rheumatology Podcast"